Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma

41Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

Background: Human Disabled-2 (DAB2), is a multi-function signalling molecule that it is frequently down-regulated in human cancers. We aimed to investigate the possible tumour suppressor effect of DAB2 in nasopharyngeal carcinoma (NPC).Methods: We studied the expression of DAB2 in NPC cell lines, xenografts and primary tumour samples. The status of promoter methylation was assessed by methylation specific PCR and bisulfite sequencing. The functional role of DAB2 in NPC was investigated by re-introducing DAB2 expression into NPC cell line C666-1.Results: Decrease or absent of DAB2 transcript was observed in NPC cell lines and xenografts. Loss of DAB2 protein expression was seen in 72% (33/46) of primary NPC as demonstrated by immunohistochemistry. Aberrant DAB2 promoter methylation was detected in 65.2% (30/46) of primary NPC samples by methylation specific PCR. Treatment of the DAB2 negative NPC cell line C666-1 with 5-aza-2'-deoxycytidine resulted in restoration of DAB2 expression in a dose-dependent manner. Overexpression of DAB2 in NPC cell line C666-1 resulted in reduced growth rate and 35% reduction in anchorage-dependent colony formation, and inhibition of serum-induced c-Fos expression compared to vector-transfected controls. Over expression of DAB2 resulted in alterations of multiple pathways as demonstrated by expression profiling and functional network analysis, which confirmed the role of DAB2 as an adaptor molecule involved in multiple receptor-mediated signalling pathways.Conclusions: We report the frequent down regulation of DAB2 in NPC and the promoter hypermethylation contributes to the loss of expression of DAB2. This is the first study demonstrating frequent DAB2 promoter hypermethylation in human cancer. Our functional studies support the putative tumour suppressor effect of DAB2 in NPC cells. © 2010 Tong et al; licensee BioMed Central Ltd.

References Powered by Scopus

Analysis of relative gene expression data using real-time quantitative PCR and the 2<sup>-ΔΔC</sup>T method

149989Citations
N/AReaders
Get full text

Focus on nasopharyngeal carcinoma

498Citations
N/AReaders
Get full text

Nasopharyngeal carcinoma - Review of the molecular mechanisms of tumorigenesis

287Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Integrin traffic-the update

255Citations
N/AReaders
Get full text

Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches

194Citations
N/AReaders
Get full text

Targeting the signaling in Epstein–Barr virus-associated diseases: mechanism, regulation, and clinical study

69Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Tong, J. H., Ng, D. C., Chau, S. L., So, K. K., Leung, P. P., Lee, T. L., … To, K. F. (2010). Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma. BMC Cancer, 10. https://doi.org/10.1186/1471-2407-10-253

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 14

50%

Researcher 9

32%

Professor / Associate Prof. 5

18%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 13

45%

Medicine and Dentistry 9

31%

Biochemistry, Genetics and Molecular Bi... 6

21%

Social Sciences 1

3%

Save time finding and organizing research with Mendeley

Sign up for free